A detailed history of 683 Capital Management, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 600,000 shares of SAGE stock, worth $2.95 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
600,000
Previous 500,000 20.0%
Holding current value
$2.95 Million
Previous $5.43 Million 20.33%
% of portfolio
0.39%
Previous 0.49%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.02 - $13.08 $702,000 - $1.31 Million
100,000 Added 20.0%
600,000 $4.33 Million
Q2 2024

Aug 14, 2024

BUY
$10.58 - $17.9 $3.17 Million - $5.37 Million
300,000 Added 150.0%
500,000 $5.43 Million
Q1 2024

May 15, 2024

BUY
$18.62 - $26.95 $3.72 Million - $5.39 Million
200,000 New
200,000 $3.75 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $292M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.